Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ezetimibe + fenofibrate versus pravastatin for protease inhibitor-associated dyslipidemia in HIV-infected adults
2008-005049-48Phase 4Active
- Sponsor
- ASST Sette Laghi
- Start
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in dyslipidemia and human immunodeficiency virus infection (HIV) comparing Ezetimibe + fenofibrate with Pravastatin monotherapy (2 arms). Primary endpoint: Percent change in LDL cholesterol. Started Jan 2009; status: active.
02
Drugs
ezetimibefenofibratepravastatin
03
Conditions
dyslipidemiahuman immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2008-005049-48.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005049-48.